Clinical Trial Update: VAC 072-An Efficacy Study of R21/MM in Different Dose Schedules [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating different dose schedules of R21/MM for malaria has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• R21/MM (R21 malaria vaccine with Matrix-M adjuvant)

Snippet

Sponsor: University of Oxford | Conditions: Malaria | Phase 1, Phase 2 | Status: COMPLETED